Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Cyanotech (CYAN) Competitors

Cyanotech logo

CYAN vs. HAPP, BGXX, IMCC, UPXI, AKAN, BON, SMFL, CRON, TLRY, and USNA

Should you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Bright Green (BGXX), IM Cannabis (IMCC), Upexi (UPXI), Akanda (AKAN), Bon Natural Life (BON), Smart for Life (SMFL), Cronos Group (CRON), Tilray (TLRY), and USANA Health Sciences (USNA). These companies are all part of the "medicinals & botanicals" industry.

Cyanotech vs.

Cyanotech (NASDAQ:CYAN) and Happiness Development Group (NASDAQ:HAPP) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings.

Cyanotech has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Comparatively, Happiness Development Group has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500.

Cyanotech has higher earnings, but lower revenue than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cyanotech$23.07M0.11-$5.27M-$0.66-0.56
Happiness Development Group$95.59M0.10-$49.19M$0.482.96

In the previous week, Happiness Development Group had 2 more articles in the media than Cyanotech. MarketBeat recorded 2 mentions for Happiness Development Group and 0 mentions for Cyanotech. Happiness Development Group's average media sentiment score of 0.73 beat Cyanotech's score of 0.00 indicating that Happiness Development Group is being referred to more favorably in the news media.

Company Overall Sentiment
Cyanotech Neutral
Happiness Development Group Positive

Cyanotech received 101 more outperform votes than Happiness Development Group when rated by MarketBeat users. Likewise, 63.68% of users gave Cyanotech an outperform vote while only 62.79% of users gave Happiness Development Group an outperform vote.

CompanyUnderperformOutperform
CyanotechOutperform Votes
128
63.68%
Underperform Votes
73
36.32%
Happiness Development GroupOutperform Votes
27
62.79%
Underperform Votes
16
37.21%

24.4% of Cyanotech shares are held by institutional investors. Comparatively, 15.2% of Happiness Development Group shares are held by institutional investors. 29.1% of Cyanotech shares are held by insiders. Comparatively, 15.6% of Happiness Development Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Cyanotech-19.50% -44.71% -19.12%
Happiness Development Group N/A N/A N/A

Summary

Happiness Development Group beats Cyanotech on 9 of the 15 factors compared between the two stocks.

Remove Ads
Get Cyanotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYAN vs. The Competition

MetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$2.63M$1.17B$5.64B$8.08B
Dividend YieldN/AN/A4.89%4.04%
P/E Ratio-0.5647.3523.7319.00
Price / Sales0.114.37381.75120.61
Price / CashN/A10.4038.0534.64
Price / Book0.282.076.904.26
Net Income-$5.27M-$53.22M$3.18B$247.00M

Cyanotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYAN
Cyanotech
N/A$0.37
-0.8%
N/A+2.5%$2.63M$23.07M-0.5695
HAPP
Happiness Development Group
N/A$1.39
+7.3%
N/A-25.3%$9.67M$95.59M2.90215High Trading Volume
BGXX
Bright Green
N/A$0.03
-3.2%
N/A-80.9%$6.31MN/A-0.552
IMCC
IM Cannabis
0.8112 of 5 stars
$2.00
-3.4%
N/A-4.8%$4.46M$51.39M-0.59340Short Interest ↑
Positive News
Gap Up
UPXI
Upexi
1.7795 of 5 stars
$2.73
-14.7%
N/A-75.6%$3.61M$18.63M0.00130Short Interest ↓
High Trading Volume
AKAN
Akanda
N/A$1.62
-4.1%
N/A-90.2%$2.31M$2.51M0.00110News Coverage
BON
Bon Natural Life
N/A$1.02
+3.6%
N/A-79.5%$1.20M$23.84M0.00100Positive News
Gap Down
High Trading Volume
SMFL
Smart for Life
N/A$0.01
+45.5%
N/A-99.9%$57,000.00$11.11M0.00110High Trading Volume
CRON
Cronos Group
1.563 of 5 stars
$1.97
-3.9%
$3.00
+52.3%
-4.0%$753.59M$117.62M-15.15450
TLRY
Tilray
1.8108 of 5 stars
$0.68
-7.0%
$2.70
+295.1%
-63.5%$640.79M$210.48M-2.282,650Gap Up
USNA
USANA Health Sciences
4.1598 of 5 stars
$29.97
+1.3%
$36.00
+20.1%
-32.5%$571.21M$854.50M10.591,800Insider Trade
Remove Ads

Related Companies and Tools


This page (NASDAQ:CYAN) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners